Home/Filings/4/0000950170-25-000624
4//SEC Filing

Emany Sravan Kumar 4

Accession 0000950170-25-000624

CIK 0001745999other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 8:04 PM ET

Size

7.2 KB

Accession

0000950170-25-000624

Insider Transaction Report

Form 4
Period: 2024-12-31
Emany Sravan Kumar
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2024-12-31+80,00080,000 total
  • Award

    Stock Option (Right to Buy)

    2024-12-31+160,000160,000 total
    Exercise: $24.80Exp: 2034-12-31Common Stock (160,000 underlying)
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSU vests in four substantially equal installments on each of the first four anniversaries of December 31, 2024, subject to the Reporting Person's continued service with BEAM through each vesting date.
  • [F2]This stock option vests as to 25% on the first anniversary of the vesting commencement date, December 31, 2024, and at a rate of 2.78% each month thereafter until the option is fully vested.

Documents

1 file

Issuer

Beam Therapeutics Inc.

CIK 0001745999

Entity typeother

Related Parties

1
  • filerCIK 0001897662

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 8:04 PM ET
Size
7.2 KB